Helmholtz Centre Munich
Ingolstädter Landstraße 1
D-85764 Neuherberg

Germany

 Homepage

Project Leader

Dr. Soile Tapio Phone: +49 (0)89 3187 3445  Fax: +49(0)89 3187 3378  Contact

Project Staff

Dr. Franka Pluder Post-doc  Phone: +49(0)89 3187 3855  Fax: +49(0)89 3187 3378  Contact

Dr. Dominik Schmaltz Post-doc  Phone: +49(0)89 3187 3887  Fax: +49(0)89 3187 3378  Contact

Institute Presentation

The Helmholtz Centre Munich (HELMUC) is a research institution of the Federal Government and the State of Bavaria within the Helmholtz Association of German Research Centres, the largest scientific organisation in Germany.
The Helmholtz Association is a community of 15 scientific-technical and biological-medical research centres. These centres have been commissioned with pursuing long-term research goals on behalf of the state and society. The Association strives to gain insights and knowledge so that it can help to preserve and improve the foundations of human life. It does this by identifying and working on the grand challenges faced by society, science and industry. Helmholtz Centres perform top-class research in strategic programmes in six core fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter, Transport and Space.

The mission of HELMUC is to research for a better understanding of the connection between health and the environment and work on the foundations and applications of a future medicine to treat complex chronic diseases.
HELMUC has a long tradition of contributing to EU programmes in the life sciences. Resources of the centre will be made available to the project, including the Proteomic Core Facility and Genome Analysis Centre. HELMUC has recently restructured radiation research to ling the Institutes of Radiation Biology, Radiation Protection and Molecular Radiation Biology into the National Centre for Radiation Sciences (NCRS). Over 100 scientists contribute to the integrated research programme of the NCRS into the health and environment aspects of radiation.

Research in the Institute of Radiation Biology focuses on the mechanisms of action of ionising radiation. The main aim is to determine the biological effectiveness of different types of radiation using microdosimetry, to develop improved risk models for low doses of ionising radiation using new statistical and numerical methods, to evaluate the impact of radiation therapy in individuals, and to elucidate indirect radiation effects through free radicals.
The Proteomics Group of the Institute investigates the proteome alterations of cellular and tissue / organ response at low doses and low dose rates of ionising radiation, including both non-carcinogenic (cardiovascular) and carcinogenic endpoints.